JB Therapeutics, Inc.
Records under this name other than patents JB Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to JB Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,637,087 | Treatment of interstitial cystitis using (6aR, 10aR)-Δ8-tetrahydrocannabinol-11-OIC acids Formerly held Term ended Term ended Dec 13, 2025 · USPTO record | Term ended | Term ended Dec 13, 2025 | USPTO record |
| US 5,338,753 | (3R,4R)-.DELTA..sup.6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesics Term ended Term ended no later than Aug 16, 2014 · Low confidence | Term ended | Term ended no later than Aug 16, 2014 | Low confidence |